logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Histamine-1 Receptor Antagonist class drugs

    FiltersReset Filters
    10 results

    • azelastine hydrochloride

      (Azelastine)
      AvKARE
      Usage: Azelastine hydrochloride nasal spray, 0.1%, is indicated for treating symptoms of seasonal allergic rhinitis in individuals 5 years and older, and for vasomotor rhinitis in those 12 years and older.

    • bepreve

      (bepotastine besilate)
      Bausch & Lomb Incorporated
      Usage: BEPREVE® (bepotastine besilate ophthalmic solution) 1.5% is indicated for treating itching linked to allergic conjunctivitis symptoms.

    • carbinoxamine maleate

      (CARBINOXAMINE MALEATE)
      BluCrest Pharmaceuticals, LLC
      Usage: Carbinoxamine maleate is indicated for the symptomatic treatment of seasonal and perennial allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin manifestations, dermatographism, and as an adjunctive therapy for anaphylactic reactions and allergic reactions to blood or plasma.

    • carbinoxamine maleate

      (Carbinoxamine Maleate)
      Biocomp Pharma, Inc.
      Usage: Carbinoxamine maleate is indicated for the symptomatic treatment of seasonal and perennial allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin conditions, dermatographism, as adjunct therapy for anaphylactic reactions, and to reduce the severity of allergic reactions to blood or plasma.

    • cetirizine hydrochloride

      (CETIRIZINE HYDROCHLORIDE)
      Rising Pharma Holdings, Inc.
      Usage: Cetirizine hydrochloride oral solution is indicated for treating uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children aged 6 months to 5 years, significantly reducing the occurrence, severity, and duration of hives and alleviating itching.

    • cetirizine hydrochloride oral solution

      (Cetirizine Hydrochloride Oral Solution)
      APOZEAL PHARMACEUTICALS INC
      Usage: Cetirizine Hydrochloride Oral Solution is indicated for relieving symptoms of perennial allergic rhinitis in children 6 to 23 months and treating chronic idiopathic urticaria in children 6 months to 5 years, effectively reducing sneezing, nasal and ocular symptoms, and hive-related discomfort.

    • desloratadine

      (DESLORATADINE)
      Lupin Pharmaceuticals, Inc.
      Usage: Desloratadine tablets are indicated for relieving nasal and non-nasal symptoms of seasonal and perennial allergic rhinitis in patients aged 12 and older.

    • dymista

      (Azelastine Hydrochloride and Fluticasone Propionate)
      Meda Pharmaceuticals Inc.
      Usage: DYMISTA is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and children aged 6 years and older.

    • levocetirizine dihydrochloride

      (Levocetirizine dihydrochloride)
      Padagis Israel Pharmaceuticals Ltd
      Usage: Levocetirizine dihydrochloride is indicated for relieving symptoms of perennial allergic rhinitis in children aged 6 months to 2 years and for treating uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children aged 6 months and older.

    • quzyttir

      (Cetirizine Hydrochloride)
      TerSera Therapeutics LLC
      Usage: QUZYTTIR™ is indicated for the treatment of acute urticaria in adults and children aged 6 months and older. It is not recommended for pediatric patients under 6 years with impaired renal or hepatic function.